FALCO HOLDINGS Co., Ltd. (4671.T)
JPY 2329.0
(1.48%)
JPY 2329.0
(1.48%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 2.15 Billion JPY | -29.98% |
| 2022 | 3.07 Billion JPY | -44.05% |
| 2021 | 5.49 Billion JPY | 110.25% |
| 2020 | 2.61 Billion JPY | 651.15% |
| 2019 | 348 Million JPY | -73.99% |
| 2018 | 1.33 Billion JPY | -39.48% |
| 2017 | 2.21 Billion JPY | 2.93% |
| 2016 | 2.14 Billion JPY | 1.61% |
| 2015 | 2.11 Billion JPY | 26.21% |
| 2014 | 1.67 Billion JPY | 49.96% |
| 2013 | 1.11 Billion JPY | -47.51% |
| 2012 | 2.12 Billion JPY | -1.75% |
| 2011 | 2.16 Billion JPY | 8.08% |
| 2010 | 2 Billion JPY | 0.0% |
| 2009 | - JPY | -100.0% |
| 2008 | 1.02 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 380 Million JPY | -46.4% |
| 2023 Q4 | 709 Million JPY | 19.76% |
| 2023 Q3 | 592 Million JPY | -1.66% |
| 2023 Q2 | 602 Million JPY | 141.77% |
| 2023 Q1 | 249 Million JPY | -56.01% |
| 2023 FY | 2.15 Billion JPY | -29.98% |
| 2022 FY | 3.07 Billion JPY | -44.05% |
| 2022 Q3 | 768 Million JPY | -27.55% |
| 2022 Q1 | 681 Million JPY | -59.99% |
| 2022 Q2 | 1.06 Billion JPY | 55.65% |
| 2022 Q4 | 566 Million JPY | -26.3% |
| 2021 Q3 | 658 Million JPY | -64.6% |
| 2021 Q1 | 1.27 Billion JPY | 23.38% |
| 2021 FY | 5.49 Billion JPY | 110.25% |
| 2021 Q2 | 1.85 Billion JPY | 45.58% |
| 2021 Q4 | 1.7 Billion JPY | 158.66% |
| 2020 Q3 | 867 Million JPY | 2.24% |
| 2020 Q2 | 848 Million JPY | 723.53% |
| 2020 Q4 | 1.03 Billion JPY | 19.38% |
| 2020 FY | 2.61 Billion JPY | 651.15% |
| 2020 Q1 | -136 Million JPY | -169.74% |
| 2019 Q3 | -36 Million JPY | -108.65% |
| 2019 Q1 | 266 Million JPY | 107.81% |
| 2019 FY | 348 Million JPY | -73.99% |
| 2019 Q4 | 195 Million JPY | 641.67% |
| 2019 Q2 | 416 Million JPY | 56.39% |
| 2018 Q3 | 500 Million JPY | 28.53% |
| 2018 FY | 1.33 Billion JPY | -39.48% |
| 2018 Q4 | 128 Million JPY | -74.4% |
| 2018 Q2 | 389 Million JPY | 21.18% |
| 2018 Q1 | 321 Million JPY | -43.59% |
| 2017 Q4 | 569 Million JPY | 24.51% |
| 2017 Q1 | 541 Million JPY | -2.17% |
| 2017 Q3 | 457 Million JPY | -29.04% |
| 2017 Q2 | 644 Million JPY | 19.04% |
| 2017 FY | 2.21 Billion JPY | 2.93% |
| 2016 Q4 | 553 Million JPY | -0.54% |
| 2016 Q2 | 653 Million JPY | 69.17% |
| 2016 Q3 | 556 Million JPY | -14.85% |
| 2016 Q1 | 386 Million JPY | -32.4% |
| 2016 FY | 2.14 Billion JPY | 1.61% |
| 2015 Q1 | 531 Million JPY | 33.75% |
| 2015 Q3 | 616 Million JPY | 55.56% |
| 2015 Q2 | 396 Million JPY | -25.42% |
| 2015 FY | 2.11 Billion JPY | 26.21% |
| 2015 Q4 | 571 Million JPY | -7.31% |
| 2014 Q3 | 448 Million JPY | -15.47% |
| 2014 Q4 | 397 Million JPY | -11.38% |
| 2014 FY | 1.67 Billion JPY | 49.96% |
| 2014 Q1 | 300 Million JPY | 320.59% |
| 2014 Q2 | 530 Million JPY | 76.67% |
| 2013 Q2 | 397 Million JPY | -35.34% |
| 2013 FY | 1.11 Billion JPY | -47.51% |
| 2013 Q1 | 614 Million JPY | 33.77% |
| 2013 Q3 | 242 Million JPY | -39.04% |
| 2013 Q4 | -136 Million JPY | -156.2% |
| 2012 Q3 | 586 Million JPY | 10.36% |
| 2012 FY | 2.12 Billion JPY | -1.75% |
| 2012 Q2 | 531 Million JPY | -3.8% |
| 2012 Q1 | 552 Million JPY | 203.3% |
| 2012 Q4 | 459 Million JPY | -21.67% |
| 2011 FY | 2.16 Billion JPY | 8.08% |
| 2011 Q2 | 605 Million JPY | 0.17% |
| 2011 Q4 | 182 Million JPY | -76.52% |
| 2011 Q3 | 775 Million JPY | 28.1% |
| 2011 Q1 | 604 Million JPY | 19.37% |
| 2010 FY | 2 Billion JPY | 0.0% |
| 2010 Q3 | 631 Million JPY | 10.12% |
| 2010 Q2 | 573 Million JPY | 96.23% |
| 2010 Q1 | 292 Million JPY | 0.0% |
| 2010 Q4 | 506 Million JPY | -19.81% |
| 2009 Q3 | 395 Million JPY | 0.0% |
| 2009 FY | - JPY | -100.0% |
| 2009 Q4 | - JPY | -100.0% |
| 2008 Q3 | 456 Million JPY | 0.0% |
| 2008 Q4 | 140 Million JPY | -69.3% |
| 2008 FY | 1.02 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Shin Nippon Biomedical Laboratories, Ltd. | 4.16 Billion JPY | 48.299% |
| DNA Chip Research Inc. | -258.21 Million JPY | 933.411% |
| Cosmo Bio Company,Limited | 519 Million JPY | -314.644% |
| H.U. Group Holdings, Inc. | -4.04 Billion JPY | 153.228% |
| BML, Inc. | 9.16 Billion JPY | 76.527% |
| Human Metabolome Technologies, Inc. | 220.16 Million JPY | -877.435% |
| Precision System Science Co., Ltd. | -956.24 Million JPY | 325.047% |